Sobi - Swedish Orphan Biovitrum AB (publ) kompaniyasidagi eng so‘nggi ish o‘rinlari

Sobi - Swedish Orphan Biovitrum AB (publ) develops and provides treatments for people living with rare diseases. The global biopharmaceutical company works across haematology and immunology, with research focused on conditions including haemophilia and immune thrombocytopenia. Its work also includes collaborations aimed at advancing treatment options and improving access to medicines for people with rare and debilitating conditions. Sobi’s teams span healthcare, biotechnology and pharmaceuticals, combining research and development with efforts in patient access, sustainability and humanitarian aid.